Condition
Hemorrhagic Transformation Due to Acute Stroke
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
P 2 (2)
P 3 (1)
Trial Status
Completed2
Unknown1
Recruiting1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07422636Completed
Wet and Dry Biomarkers to Predict Secondary Injury in Stroke: From Bench to Bedside - The NIMBLE Study
NCT06878066Phase 3Recruiting
Thrombolysis in Factor Xa-inhibitors Trial
NCT05725694Unknown
Acute Ischaemic STROKE: From LAboratory to the Patient's BED
NCT05670028Phase 2Not Yet Recruiting
Cerebral Autoregulation Guiding Blood Pressure Management After Revascularization
NCT01428401Phase 2Completed
Astragalus Membranaceus for Brain Edema Induced by Hemorrhagic Stroke
Showing all 5 trials